This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1y4c
From Proteopedia
|
Designed Helical Protein fusion MBP
Overview
An IL-4 antagonist was designed based on structural and biochemical, analysis of unbound IL-4 and IL-4 in complex with its high-affinity, receptor (IL-4Ralpha). Our design strategy sought to capture a, protein-protein interaction targeting the high affinity that IL-4 has for, IL-4Ralpha. This strategy has impact due to the potential relevance of, IL-4Ralpha as a drug target in the treatment of asthma. To mimic the IL-4, binding surface, critical side chains for receptor binding were, identified, and these side chains were transplanted onto a previously, characterized, de novo-designed four-helix protein called designed helical, protein 1 (DHP-1). This first-generation design resolved the ambiguity, previously described for the connectivity between helices in DHP-1 and, resulted in a protein capable of binding to IL-4Ralpha. The, second-generation antagonist was based upon further molecular modeling, and it succeeded in binding IL-4Ralpha better than the first-generation., This protein, termed DHP-14-AB, yielded a protein with a cooperative, unfolding transition (DeltaGu0=8.1 kcal/mol) and an IC50 of 27 microM when, in competition with IL-4 whereas DHP-1 had no affinity for IL-4Ralpha. The, crystal structure of DHP-14-AB was determined to 1.9-A resolution and was, compared with IL-4. This comparison revealed how design strategies, targeting protein-protein interactions require high-resolution 3D data and, the incorporation of orientation-specific information at the level of, side-chains and secondary structure element interactions.
About this Structure
1Y4C is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.
Reference
De novo design of an IL-4 antagonist and its structure at 1.9 A., Laporte SL, Forsyth CM, Cunningham BC, Miercke LJ, Akhavan D, Stroud RM, Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1889-94. Epub 2005 Jan 31. PMID:15684085
Page seeded by OCA on Wed Nov 21 06:33:33 2007
